当前位置: X-MOL 学术Sci. Signal. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Probing the mutational landscape of regulators of G protein signaling proteins in cancer.
Science Signaling ( IF 6.7 ) Pub Date : 2020-02-04 , DOI: 10.1126/scisignal.aax8620
Vincent DiGiacomo 1 , Marcin Maziarz 1 , Alex Luebbers 1 , Jillian M Norris 1 , Pandu Laksono 1 , Mikel Garcia-Marcos 1
Affiliation  

The advent of deep-sequencing techniques has revealed that mutations in G protein-coupled receptor (GPCR) signaling pathways in cancer are more prominent than was previously appreciated. An emergent theme is that cancer-associated mutations tend to cause enhanced GPCR pathway activation to favor oncogenicity. Regulators of G protein signaling (RGS) proteins are critical modulators of GPCR signaling that dampen the activity of heterotrimeric G proteins through their GTPase-accelerating protein (GAP) activity, which is conferred by a conserved domain dubbed the "RGS-box." Here, we developed an experimental pipeline to systematically assess the mutational landscape of RGS GAPs in cancer. A pan-cancer bioinformatics analysis of the 20 RGS domains with GAP activity revealed hundreds of low-frequency mutations spread throughout the conserved RGS domain structure with a slight enrichment at positions that interface with G proteins. We empirically tested multiple mutations representing all RGS GAP subfamilies and sampling both G protein interface and noninterface positions with a scalable, yeast-based assay. Last, a subset of mutants was validated using G protein activity biosensors in mammalian cells. Our findings reveal that a sizable fraction of RGS protein mutations leads to a loss of function through various mechanisms, including disruption of the G protein-binding interface, loss of protein stability, or allosteric effects on G protein coupling. Moreover, our results also validate a scalable pipeline for the rapid characterization of cancer-associated mutations in RGS proteins.

中文翻译:

探索癌症中G蛋白信号蛋白调节因子的突变态势。

深度测序技术的出现揭示了癌症中G蛋白偶联受体(GPCR)信号通路的突变比以前认识的更为突出。一个新兴的主题是与癌症相关的突变倾向于引起增强的GPCR途径活化,从而有利于致癌性。G蛋白信号转导(RGS)蛋白的调节剂是GPCR信号转导的关键调节剂,可通过其GTPase加速蛋白(GAP)活性抑制异源三聚体G蛋白的活性,该活性由称为“ RGS-box”的保守结构域赋予。在这里,我们开发了一条实验管道,可以系统地评估RGS GAP在癌症中的突变情况。对具有GAP活性的20个RGS结构域的全癌生物信息学分析显示,数百个低频突变分布在整个RGS结构域保守结构中,在与G蛋白接触的位置略有富集。我们根据经验测试了代表所有RGS GAP亚家族的多个突变,并使用基于酵母的可扩展分析方法对G蛋白界面和非界面位置进行了采样。最后,在哺乳动物细胞中使用G蛋白活性生物传感器验证了突变体的子集。我们的发现表明,RGS蛋白突变的相当大一部分会通过各种机制导致功能丧失,包括G蛋白结合界面的破坏,蛋白稳定性的丧失或对G蛋白偶联的变构作用。此外,
更新日期:2020-02-04
down
wechat
bug